North America Dengue Diagnostics Market Size & Outlook
Related Markets
North America dengue diagnostics market highlights
- The North America dengue diagnostics market generated a revenue of USD 33.7 million in 2024.
- The market is expected to grow at a CAGR of 0.7% from 2025 to 2030.
- In terms of segment, elisa-based tests was the largest revenue generating product in 2024.
- NS1 Antigen Detection Kits is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Mexico is expected to register the highest CAGR from 2025 to 2030.
North America data book summary
| Market revenue in 2024 | USD 33.7 million |
| Market revenue in 2030 | USD 35.0 million |
| Growth rate | 0.7% (CAGR from 2025 to 2030) |
| Largest segment | Elisa-based tests |
| Fastest growing segment | NS1 Antigen Detection Kits |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | ELISA-based Tests, Dengue IgG/IgM Detection Kits, RT-PCR Tests, Rapid Diagnostic Tests (RDTs), NS1 Antigen Detection Kits, Lateral Flow Immunoassay |
Other key industry trends
- In terms of revenue, North America region accounted for 5.5% of the global dengue diagnostics market in 2024.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Latin America is the fastest growing regional market and is projected to reach USD 248.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Dengue Diagnostics Market Scope
Dengue Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Novatec Immundiagnostica | View profile | 11-50 | Dernbach, Hessen, Germany, Europe | https://www.novatec-id.com |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| Certest Biotec | View profile | - | Zaragoza, Aragon, Spain, Europe | http://www.certest.es/ |
| InBios | View profile | 51-100 | Seattle, Washington, United States, North America | https://inbios.com/ |
| Abnova | View profile | 251-500 | Taipei, T'ai-pei, Taiwan, Asia | http://www.abnova.com/ |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | http://www.perkinelmer.com |
| Diasorin SpA | View profile | 3233 | Via Crescentino Snc, Saluggia, Vercelli, Italy, 13040 | https://www.diasoringroup.com |
| Quest Diagnostics Inc | View profile | 48000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | https://www.questdiagnostics.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
North America dengue diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dengue diagnostics market will help companies and investors design strategic landscapes.
Elisa-based tests was the largest segment with a revenue share of 44.81% in 2024. Horizon Databook has segmented the North America dengue diagnostics market based on elisa-based tests, dengue igg/igm detection kits, rt-pcr tests, rapid diagnostic tests (rdts), ns1 antigen detection kits, lateral flow immunoassay covering the revenue growth of each sub-segment from 2018 to 2030.
North America dominated the global market growth is robust driven by robust public health surveillance and expanded point‑of‑care testing adoption . The U.S. and Canada lead investments in rapid NS1 antigen assays and multiplex PCR platforms.
Increased travel‑related case importation has spurred laboratory upgrades, while federal initiatives bolster decentralized testing in clinics and urgent care centers, ensuring timely outbreak response and patient management.
Reasons to subscribe to North America dengue diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America dengue diagnostics market databook
-
Our clientele includes a mix of dengue diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America dengue diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into North America dengue diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America dengue diagnostics market size, by country, 2018-2030 (US$M)
North America Dengue Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
